Top 10 CDMOs in Europe - 2022
The market for pharmaceutical CDMOs in Europe reached $37.17 billion in 2019 and is expected to increase by 6.7% annually from 2020 to 2030 as a result of rising demand for specialty drugs and biological therapies, increased pressure to keep drug development costs under control, and rising healthcare costs.
In their capacity as adaptable third-party service providers, CDMOs assist pharmaceutical businesses throughout the whole process of producing medications, including the research and development phases as well as the manufacturing, formulation, and finishing phases. With a more dynamic mergers and acquisitions (M&A) landscape brought on by consolidation, CDMOs have grown during the past ten years.
In the past, CDMOs operated under a business model that mostly concentrated on serving as outside contractors for the production of established pharmaceuticals. This concept includes the expansion of capacity through the purchase of pharmaceutical businesses' manufacturing facilities. However, CDMOs are increasingly taking the lead in innovation, encompassing more aspects of the pharmaceutical industry than just manufacturing, and generating new sources of income. CDMOs can quickly increase their capabilities through acquisitions, enabling them to offer technically sophisticated services at scale.
In this edition of Life Sciences Review, we present the list of top CDMOs in Europe. Curtis Health Caps and Idorsia Pharmaceutical Ltd., are some of the prominent CDMOs in the region. We also bring to you thought leadership articles and exclusive insights from expert CIOs and CXOs— Stefan Abele, Senior Vice President, Head of Chemical Development and Commercial Manufacturing, Idorsia Pharmaceutical ltd., Brian D. Fry, Senior Director, Cell Therapy CDMO, Charles River Laboratories, Dr. Sarah Tregenza, Ph.D., BSc (Hons), APAC Oncology Medical Affairs Director, Pierre Fabre Group presenting their views and opinions on how organizations can incorporate changes. We hope the valuable insights from industry thought leaders and the CDMOs featured in this edition help you make informed decisions for your organization.










